Wall Street Journal: How AI Is Transforming Drug Creation


June 26, 2017

The Wall Street Journal’s Daniela Hernandez talks to BERG’s CEO Niven Narain about efforts to advance drug discovery through the use of AI. BERG’s Project Survival is featured as a key example of how we are working to improve the lives of patients.

You can read the full article here: http://on.wsj.com/2u7QfmL

Recent news